Medicago: GSK and Medicago have global plans for their Covid-19 vaccine. But WHO balks at Big Tobacco investor

Over the last couple years, GlaxoSmithKline lent its adjuvant technology to several experimental Covid-19 vaccines, and last month, the Canadian government finally came through with a first approval. But will politics surrounding the tobacco industry stand in the way of a smooth global rollout? The World Health Organization has not...